Literature DB >> 12410533

Nasopharyngeal carcinoma in situ (NPCIS)--pathologic and clinical perspectives.

Martin Wai Pak1, Ka Fai To, Y M Dennis Lo, Lisa Y S Chan, J H M Tong, Kwok Wai Lo, Charles Andrew van Hasselt.   

Abstract

BACKGROUND: Dysplasia or carcinoma in situ lesions (NPCIS) of the nasopharynx have rarely been reported. The prevalence, biologic behavior, and the transformation period of the pure preinvasive lesions have not been fully explained.
METHODS: All cases of NPCIS were retrospectively reviewed during the period between 1990 and 2000. The clinical features of all cases were studied. The biopsy samples were examined using light microscopy and in situ hybridization (ISH) for EBV-encoded RNA (EBER). The sera taken before and after the transformation were analyzed for anti-viral capsid antigen (VCA) EBV titers and circulating cell-free EBV DNA concentration.
RESULTS: Three cases of NPCIS were identified. Two of the three cases subsequently developed into invasive NPC after initial presentation. The interval of transformation varied from 40 to 48 months. In all three cases, the specimens showed abnormal findings on light microscopy and positive staining for EBER. Elevated anti-VCA titers were present in two of the preinvasive lesions. No cell-free EBV DNA was detected in the sera of these patients during the preinvasive phase of the disease.
CONCLUSIONS: Preinvasive NPC is a rare but distinct entity. Its transformation period can be as long as 4 to 5 years. Elevated anti-VCA titers, in the presence of abnormal cells on light microscopy, should alert the pathologist to perform ISH EBER studies to diagnose this rare condition. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410533     DOI: 10.1002/hed.10161

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  Update on nasopharyngeal carcinoma.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2007-11-27

2.  An update on Epstein-Barr virus and nasopharyngeal carcinogenesis.

Authors:  Bayardo Perez-Ordoñez
Journal:  Head Neck Pathol       Date:  2007-12-01

3.  Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications.

Authors:  K-B Tan; T C Putti
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

4.  Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma.

Authors:  Weitao Lin; Yim Ling Yip; Lin Jia; Wen Deng; Hong Zheng; Wei Dai; Josephine Mun Yee Ko; Kwok Wai Lo; Grace Tin Yun Chung; Kevin Y Yip; Sau-Dan Lee; Johnny Sheung-Him Kwan; Jun Zhang; Tengfei Liu; Jimmy Yu-Wai Chan; Dora Lai-Wan Kwong; Victor Ho-Fun Lee; John Malcolm Nicholls; Pierre Busson; Xuefeng Liu; Alan Kwok Shing Chiang; Kwai Fung Hui; Hin Kwok; Siu Tim Cheung; Yuk Chun Cheung; Chi Keung Chan; Bin Li; Annie Lai-Man Cheung; Pok Man Hau; Yuan Zhou; Chi Man Tsang; Jaap Middeldorp; Honglin Chen; Maria Li Lung; Sai Wah Tsao
Journal:  Nat Commun       Date:  2018-11-07       Impact factor: 14.919

Review 5.  Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma.

Authors:  Samantha Wei-Man Lun; Siu-Tim Cheung; Kwok-Wai Lo
Journal:  Chin J Cancer       Date:  2014-09-16

6.  Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.

Authors:  Meng Xu; Chartia Ching-Mei Cheung; Chit Chow; Samantha Wei-Man Lun; Siu-Tim Cheung; Kwok-Wai Lo
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.